Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Healthy Chinese Subjects-Reference-Cited by-同舟云学术

Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Healthy Chinese Subjects

Published:2018-10-31 Issue:3 Volume:44 Page:353-360
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Xie Ran,Zhang Yang,Zhao Nan,Zhou Shuang,Wang Xin,Han Wei,Yu Yan,Zhao Xia,Cui Yimin^ORCID

Funder

Shanghai Association for Science and Technology

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s13318-018-0523-5.pdf

Reference25 articles.

1. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002;13(4–5):323–40.

2. Arend WP, Joslin FG, Massoni RJ. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol. 1985;134(6):3868–75.

3. Kirisawa R, Fukuda T, Yamanaka H. Enzymatic amplification and expression of bovine interleukin-1 receptor antagonist cDNA. Vet Immunol Immunopathol. 1998;62(3):197–208.

4. Hannum CH, Wilcox CJ, Arend WP. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990;343(6256):336–40.

5. Eisenberg SP, Evans RJ, Arend WP. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990;343(6256):341–6.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis;Pharmaceuticals;2024-02-19

2. Unveiling cytokine charge disparity as a potential mechanism for immune regulation;Cytokine & Growth Factor Reviews;2023-12

3. Decoy Interleukin-1 Receptor Antagonist on Extracellular Vesicles;Journal of Biomaterials and Tissue Engineering;2023-04-01

4. Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas;Heliyon;2023-04

5. Interleukin-1 Receptor Antagonist: A Promising Cytosine In Human Squamous Epithelial Cell Carcinoma;SSRN Electronic Journal;2022